(Q63063317)
Statements
A Phase II, Double-blind, Placebo-controlled, Randomised, 6-way Cross-over, Single-dose Study to Investigate the Local and Systemic Effects of 3 Doses of Inhaled AZD3199 (a β2-agonist) Compared to Formoterol in Asthmatic Patients (English)
0 references
August 2008
0 references
December 2008
0 references
37
0 references
18 year
0 references